Holding(s) in Company

RNS Number : 0483Q

Spire Healthcare Group PLC

26 August 2014

 



TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES

1.   Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Spire Healthcare Group plc

2. Reason for the notification (please state Yes/No):

An acquisition or disposal of voting rights: (YES)

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:

An event changing the breakdown of voting rights: (    )

Other (please specify)

3. Full name of person(s) subject to the notification obligation:

Cinven Limited
Cinven S.A

4. Full name of shareholder(s) (if different from 3.):

FOURTH CINVEN FUND (NO.1) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (NO.2) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (NO.3-VCOC) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (NO.4) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (UBTI) LIMITED PARTNERSHIP

FOURTH CINVEN FUND FCPR

FOURTH CINVEN FUND CO-INVESTMENT PARTNERSHIP

FOURTH CINVEN (MACIF) LIMITED PARTNERSHIP

5. Date of the transaction (and date on which the threshold is crossed or reached if different): 21 August 2014

6. Date on which issuer notified: 26 August 2014

7. Threshold(s) that is/are crossed or reached: 3%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of Shares	Number of Voting Rights	Number of shares	Number of voting rights			% of  voting rights x
			Direct	Direct xi		Indirect xii	Direct	Indirect
ORDINARY ISIN: GB00BNLPYF73
FOURTH CINVEN FUND (NO.1) LIMITED PARTNERSHIP	43,914,666	43,914,666	45,505,672	45,505,672			11.346%
FOURTH CINVEN FUND (NO.2) LIMITED PARTNERSHIP	45,820,729	45,820,729	47,480,791	47,480,791			11.838%
FOURTH CINVEN FUND (NO.3-VCOC) LIMITED PARTNERSHIP	45,429,522	45,429,522	47,075,410	47,075,410			11.737%
FOURTH CINVEN FUND (NO.4) LIMITED PARTNERSHIP	43,355,266	43,355,266	44,926,005	44,926,005			11.201%
FOURTH CINVEN FUND (UBTI) LIMITED PARTNERSHIP	24,391,287	24,391,287	25,274,971	25,274,971			6.302%
FOURTH CINVEN FUND FCPR	20,068,168	20,068,168	20,795,227	20,795,227			5.185%
FOURTH CINVEN FUND CO-INVESTMENT PARTNERSHIP	2,229,797	2,229,797	2,310,581	2,310,581			0.576%
FOURTH CINVEN (MACIF) LIMITED PARTNERSHIP	638,063	638,063	661,181	661,181			0.165%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration Date

Exercise/Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument	Exercise price	Expiration date	Exercise/Conversion period	Number of voting rights instrument refers to	% of voting rights
					Nominal	Delta

Total (A+B+C)

Number of voting rights	% of voting rights
234,029,838	58.35%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Cinven Limited acts as manager of the following entities:

Fourth Cinven Fund (No.1) Limited Partnership

Fourth Cinven Fund (NO.2) Limited Partnership

Fourth Cinven Fund (NO.3-VCOC) Limited Partnership

Fourth Cinven Fund (NO.4) Limited Partnership

Fourth Cinven Fund ND (UBTI) Limited Partnership

Fourth Cinven (MACIF) Limited Partnership,

together the "Cinven Funds".

The Cinven Funds and Fourth Cinven Fund Co-Investment Partnership are party to an agreement whereby Fourth Cinven Fund Co-Investment Partnership acts in accordance with the actions of the Cinven Funds, meaning that Cinven Limited also effectively controls Fourth Cinven Fund Co-Investment Partnership.

Cinven S.A. acts as manager of Fourth Cinven Fund FCPR.

Proxy Voting:

10. Name of the proxy holder:                                                                N/A

11. Number of voting rights proxy holder will cease to hold:        N/A

12. Date on which proxy holder will cease to hold voting rights: N/A

13. Additional information:

14. Contact name:

Anthony Dand, Interim Deputy Secretary, Spire healthcare Group plc

15. Contact telephone number:

+ 44 (0)20 7427 9092

 

END

 

 

HOLUNAVRSBAWUAR